Draganić-Gajić Saveta, Lecić-Tosevski Dusica, Svrakić Dragan, Paunovic Vladimir R, Cvejić Vesna, Cloninger Robert
Medicinski fakultet, Beograd, Institut za mentalno zdravlje.
Med Pregl. 2008 Jul-Aug;61(7-8):383-8. doi: 10.2298/mpns0808383d.
In this study we test the hypothesis that specific behavioral and biochemical vulnerabilities characterize individuals with hyperthyroidism-Graves type, one of the classically cited "psychosomatic disorders".
The sample included 24 subjects with Graves disease and 34 controls. All participants were evaluated for personality and temperament characteristics and for platelet MAO activity. A smaller group of panic disorder patients was tested with the same set of measures to ensure a validity of the study, especially regarding results on personality tests.
Individuals with hyperthyroidism had lower platelet MAO activity and higher scores on histrionic (Hy), depressive (D) and hypochondriac (H) subscale on the MMPI-201 than normal controls. Their TPQ temperament scores were characterized by high Harm Avoidance, whereas other temperament traits were average. Platelet MAO activity was inversely correlated with the MMPI-201 psychopatic deviance scale (Pd) and positively correlated with the TPQ Reward Dependence scale.
Our results provide support for the psychosomatic concept of Graves' disease. Personality features, temperament traits, and platelet MAO activity of hyperthyroid individuals are different from those in normal controls and correspond to those observed in anxiety disorders. We propose that the observed behavioral and biochemical similaritites between hyperthyroid and anxiety disorder patients represent an equicausality phenomenon, where the same underlying heritable factors, such as variable central monoaminergic activity coupled with temperament-related susceptibility to stress, facilitate phenotypic manifestation of a number of psychosomatic and psychialric disorders--including Graves disease. The observed correlations between personality traits and MAO activity provide support for the hypothesized functional relationship between the underlying central monoaminergic activity and temperament traits associated with anxiety, depression, and impulsivity.
在本研究中,我们检验这样一个假设,即特定的行为和生化易损性是患有甲状腺功能亢进症 - 格雷夫斯型患者的特征,这是经典提及的“身心障碍”之一。
样本包括24名格雷夫斯病患者和34名对照者。所有参与者都被评估了人格和气质特征以及血小板单胺氧化酶(MAO)活性。一组较小的恐慌症患者用相同的一组测量方法进行测试,以确保研究的有效性,特别是关于人格测试的结果。
甲状腺功能亢进症患者的血小板MAO活性较低,在MMPI - 201的表演型(Hy)、抑郁型(D)和疑病型(H)分量表上的得分高于正常对照者。他们的TPQ气质得分以高回避伤害为特征,而其他气质特征为平均水平。血小板MAO活性与MMPI - 201精神病态偏离量表(Pd)呈负相关,与TPQ奖励依赖量表呈正相关。
我们的结果为格雷夫斯病的身心概念提供了支持。甲状腺功能亢进个体的人格特征、气质特征和血小板MAO活性与正常对照者不同,且与焦虑症中观察到的特征相符。我们提出,甲状腺功能亢进症患者和焦虑症患者之间观察到的行为和生化相似性代表了一种等因果关系现象,其中相同的潜在遗传因素,如可变的中枢单胺能活性以及与气质相关的应激易感性,促进了包括格雷夫斯病在内的多种身心和精神障碍的表型表现。人格特质与MAO活性之间观察到的相关性为潜在的中枢单胺能活性与与焦虑、抑郁和冲动相关的气质特质之间的假设功能关系提供了支持。